Detailed Mechanism Funding and Narrative

Years of mechanism: 2017 2018 2019 2020

Details for Mechanism ID: 18596
Country/Region: Côte d'Ivoire
Year: 2018
Main Partner: ACONDA
Main Partner Program: Cote d'Ivoire
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $6,723,710 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $393,717
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $321,272
Care: Pediatric Care and Support (PDCS) $451,783
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $419,926
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $295,616
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $4,325,963
Treatment: Pediatric Treatment (PDTX) $515,433
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV <10, Female, Physical and/or Emotional Violence 2019 1
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2019 37
GEND_GBV <10, Male, Physical and/or Emotional Violence 2019 2
GEND_GBV <10, Male, Sexual Violence (Post-Rape Care) 2019 2
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2019 1
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2019 64
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2019 3
GEND_GBV 10-14, Male, Sexual Violence (Post-Rape Care) 2019 4
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2019 4
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2019 74
GEND_GBV 15-19, Male, Sexual Violence (Post-Rape Care) 2019 1
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2019 4
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2019 31
GEND_GBV 25-29, Female, Physical and/or Emotional Violence 2019 8
GEND_GBV 25-29, Female, Sexual Violence (Post-Rape Care) 2019 27
GEND_GBV 30-34, Female, Physical and/or Emotional Violence 2019 1
GEND_GBV 30-34, Female, Sexual Violence (Post-Rape Care) 2019 2
GEND_GBV 35-39, Female, Physical and/or Emotional Violence 2019 2
GEND_GBV 35-39, Female, Sexual Violence (Post-Rape Care) 2019 1
GEND_GBV 40-49, Female, Sexual Violence (Post-Rape Care) 2019 8
GEND_GBV 50+, Female, Sexual Violence (Post-Rape Care) 2019 1
GEND_GBV By PEP service provision (related to sexual violence services provided) 2019 219
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2019 26
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2019 252
GEND_GBV Number of people receiving post-GBV care 2019 278
HTS_SELF 2019 1,467
HTS_SELF 20-24, Female, Unassisted 2019 292
HTS_SELF 25-29, Female, Unassisted 2019 475
HTS_SELF 30-34, Female, Unassisted 2019 388
HTS_SELF 35-39, Female, Unassisted 2019 243
HTS_SELF 40-49, Female, Unassisted 2019 53
HTS_SELF 50+, Female, Unassisted 2019 15
HTS_SELF Unassisted 2019 1,467
HTS_SELF Unassisted - Sex Partner 2019 1,467
HTS_TST <1, Unknown Sex, Negative 2019 137
HTS_TST <5, Unknown Sex, Negative 2019 4,471
HTS_TST 1-9, Unknown Sex, Negative 2019 769
HTS_TST 10-14, Female, Negative 2019 183
HTS_TST 10-14, Male, Negative 2019 109
HTS_TST 15-19, Female, Negative 2019 3,380
HTS_TST 15-19, Female, Negative 2019 1,967
HTS_TST 15-19, Male, Negative 2019 3,142
HTS_TST 15-19, Male, Negative 2019 1,831
HTS_TST 20-24, Female, Negative 2019 2,890
HTS_TST 20-24, Female, Negative 2019 1,682
HTS_TST 20-24, Male, Negative 2019 2,725
HTS_TST 20-24, Male, Negative 2019 1,587
HTS_TST 25-29, Female, Negative 2019 201
HTS_TST 25-29, Female, Negative 2019 140
HTS_TST 25-29, Female, Negative 2019 201
HTS_TST 25-29, Female, Negative 2019 844
HTS_TST 25-29, Female, Negative 2019 34,848
HTS_TST 25-29, Female, Negative 2019 108
HTS_TST 25-29, Female, Negative 2019 136
HTS_TST 25-29, Male, Negative 2019 1,046
HTS_TST 25-29, Male, Negative 2019 736
HTS_TST 25-29, Male, Negative 2019 1,081
HTS_TST 25-29, Male, Negative 2019 4,518
HTS_TST 25-29, Male, Negative 2019 606
HTS_TST 25-29, Male, Negative 2019 243
HTS_TST 30-34, Female, Negative 2019 201
HTS_TST 30-34, Female, Negative 2019 140
HTS_TST 30-34, Female, Negative 2019 201
HTS_TST 30-34, Female, Negative 2019 844
HTS_TST 30-34, Female, Negative 2019 23,256
HTS_TST 30-34, Female, Negative 2019 108
HTS_TST 30-34, Female, Negative 2019 160
HTS_TST 30-34, Male, Negative 2019 1,046
HTS_TST 30-34, Male, Negative 2019 736
HTS_TST 30-34, Male, Negative 2019 1,081
HTS_TST 30-34, Male, Negative 2019 4,518
HTS_TST 30-34, Male, Negative 2019 606
HTS_TST 30-34, Male, Negative 2019 264
HTS_TST 35-39, Female, Negative 2019 188
HTS_TST 35-39, Female, Negative 2019 140
HTS_TST 35-39, Female, Negative 2019 201
HTS_TST 35-39, Female, Negative 2019 844
HTS_TST 35-39, Female, Negative 2019 15,133
HTS_TST 35-39, Female, Negative 2019 108
HTS_TST 35-39, Female, Negative 2019 119
HTS_TST 35-39, Male, Negative 2019 1,003
HTS_TST 35-39, Male, Negative 2019 699
HTS_TST 35-39, Male, Negative 2019 1,011
HTS_TST 35-39, Male, Negative 2019 4,248
HTS_TST 35-39, Male, Negative 2019 581
HTS_TST 35-39, Male, Negative 2019 246
HTS_TST 40-49, Female, Negative 2019 188
HTS_TST 40-49, Female, Negative 2019 140
HTS_TST 40-49, Female, Negative 2019 201
HTS_TST 40-49, Female, Negative 2019 844
HTS_TST 40-49, Female, Negative 2019 4,718
HTS_TST 40-49, Female, Negative 2019 108
HTS_TST 40-49, Female, Negative 2019 165
HTS_TST 40-49, Male, Negative 2019 849
HTS_TST 40-49, Male, Negative 2019 597
HTS_TST 40-49, Male, Negative 2019 880
HTS_TST 40-49, Male, Negative 2019 3,667
HTS_TST 40-49, Male, Negative 2019 489
HTS_TST 40-49, Male, Negative 2019 328
HTS_TST 50+, Female, Negative 2019 1,813
HTS_TST 50+, Female, Negative 2019 1,058
HTS_TST 50+, Male, Negative 2019 1,342
HTS_TST 50+, Male, Negative 2019 777
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 363,442
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2019 458
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 19,741
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 33,610
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2019 97
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2019 242
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 1,318
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 326
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 184
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 2,344
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 2,180
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 1,987
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 1,891
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 1,268
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 951
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2019 968
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 5,275
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 1,307
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 743
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 3,397
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 3,134
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 2,850
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 2,700
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 1,849
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 1,425
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 27,202
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 6,745
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 3,821
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 14,239
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 13,237
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 11,991
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 11,470
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 7,712
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 5,910
HTS_TST Service Delivery Point (Facility) TB: <1, Negative 2019 4
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2019 65
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2019 36
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2019 31
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 101
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 95
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 135
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 169
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 213
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 316
HTS_TST Service Delivery Point (Facility)Other PITC: <1, Negative 2019 4,990
HTS_TST_POS <5, Unknown Sex, Positive 2019 312
HTS_TST_POS 1-9, Unknown Sex, Positive 2019 11
HTS_TST_POS 10-14, Female, Positive 2019 2
HTS_TST_POS 15-19, Female, Positive 2019 253
HTS_TST_POS 15-19, Female, Positive 2019 127
HTS_TST_POS 15-19, Male, Positive 2019 236
HTS_TST_POS 15-19, Male, Positive 2019 117
HTS_TST_POS 20-24, Female, Positive 2019 214
HTS_TST_POS 20-24, Female, Positive 2019 102
HTS_TST_POS 20-24, Male, Positive 2019 206
HTS_TST_POS 20-24, Male, Positive 2019 94
HTS_TST_POS 25-29, Female, Positive 2019 19
HTS_TST_POS 25-29, Female, Positive 2019 42
HTS_TST_POS 25-29, Female, Positive 2019 24
HTS_TST_POS 25-29, Female, Positive 2019 54
HTS_TST_POS 25-29, Female, Positive 2019 640
HTS_TST_POS 25-29, Female, Positive 2019 7
HTS_TST_POS 25-29, Female, Positive 2019 23
HTS_TST_POS 25-29, Male, Positive 2019 80
HTS_TST_POS 25-29, Male, Positive 2019 231
HTS_TST_POS 25-29, Male, Positive 2019 120
HTS_TST_POS 25-29, Male, Positive 2019 333
HTS_TST_POS 25-29, Male, Positive 2019 33
HTS_TST_POS 25-29, Male, Positive 2019 10
HTS_TST_POS 30-34, Female, Positive 2019 12
HTS_TST_POS 30-34, Female, Positive 2019 42
HTS_TST_POS 30-34, Female, Positive 2019 24
HTS_TST_POS 30-34, Female, Positive 2019 54
HTS_TST_POS 30-34, Female, Positive 2019 508
HTS_TST_POS 30-34, Female, Positive 2019 7
HTS_TST_POS 30-34, Female, Positive 2019 39
HTS_TST_POS 30-34, Male, Positive 2019 81
HTS_TST_POS 30-34, Male, Positive 2019 231
HTS_TST_POS 30-34, Male, Positive 2019 120
HTS_TST_POS 30-34, Male, Positive 2019 333
HTS_TST_POS 30-34, Male, Positive 2019 34
HTS_TST_POS 30-34, Male, Positive 2019 19
HTS_TST_POS 35-39, Female, Positive 2019 12
HTS_TST_POS 35-39, Female, Positive 2019 42
HTS_TST_POS 35-39, Female, Positive 2019 24
HTS_TST_POS 35-39, Female, Positive 2019 54
HTS_TST_POS 35-39, Female, Positive 2019 315
HTS_TST_POS 35-39, Female, Positive 2019 7
HTS_TST_POS 35-39, Female, Positive 2019 40
HTS_TST_POS 35-39, Male, Positive 2019 81
HTS_TST_POS 35-39, Male, Positive 2019 219
HTS_TST_POS 35-39, Male, Positive 2019 113
HTS_TST_POS 35-39, Male, Positive 2019 316
HTS_TST_POS 35-39, Male, Positive 2019 32
HTS_TST_POS 35-39, Male, Positive 2019 43
HTS_TST_POS 40-49, Female, Positive 2019 14
HTS_TST_POS 40-49, Female, Positive 2019 42
HTS_TST_POS 40-49, Female, Positive 2019 24
HTS_TST_POS 40-49, Female, Positive 2019 54
HTS_TST_POS 40-49, Female, Positive 2019 70
HTS_TST_POS 40-49, Female, Positive 2019 7
HTS_TST_POS 40-49, Female, Positive 2019 59
HTS_TST_POS 40-49, Male, Positive 2019 62
HTS_TST_POS 40-49, Male, Positive 2019 185
HTS_TST_POS 40-49, Male, Positive 2019 95
HTS_TST_POS 40-49, Male, Positive 2019 267
HTS_TST_POS 40-49, Male, Positive 2019 32
HTS_TST_POS 40-49, Male, Positive 2019 65
HTS_TST_POS 50+, Female, Positive 2019 126
HTS_TST_POS 50+, Female, Positive 2019 66
HTS_TST_POS 50+, Male, Positive 2019 92
HTS_TST_POS 50+, Male, Positive 2019 49
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 109
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 400
HTS_TST_POS Service Delivery Point (Facility) Index: <1, Positive 2019 60
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 328
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 83
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 48
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 739
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 687
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 630
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 595
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2019 396
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 295
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2019 41
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 220
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 55
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2019 33
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 382
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 354
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 327
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 306
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 208
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 153
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2019 53
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 278
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 67
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 39
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 1,083
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 1,006
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 921
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 873
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2019 580
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 431
HTS_TST_POS Service Delivery Point (Facility) TB: 1-9, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Male, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 14
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 34
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 47
PMTCT_ART Already on ART at beginning of current pregnancy 2019 1,399
PMTCT_ART New on ART 2019 2,043
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 3,442
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 134,611
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 2,661
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 668
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 3,329
PMTCT_EID Sum of Infant Age disaggregates 2019 3,329
PMTCT_STAT 25-29, Female 2019 35,861
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 432
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 34,091
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 640
PMTCT_STAT 30-34, Female 2019 24,191
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 453
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 23,256
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 508
PMTCT_STAT 35-39, Female 2019 15,704
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 311
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 15,133
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 315
PMTCT_STAT 40-49, Female 2019 4,870
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 92
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 4,718
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 71
PMTCT_STAT By Age (Numerator): 10-14 2019 459
PMTCT_STAT By Age (Numerator): 15-19 2019 19,792
PMTCT_STAT By Age (Numerator): 20-24 2019 33,633
PMTCT_STAT By Age (Numerator): 50+ 2019 101
PMTCT_STAT By Number of known positives: 15-19 2019 26
PMTCT_STAT By Number of known positives: 20-24 2019 150
PMTCT_STAT By Number of known positives: 50+ 2019 2
PMTCT_STAT By Number of new negative: 10-14 2019 458
PMTCT_STAT By Number of new negative: 15-19 2019 19,741
PMTCT_STAT By Number of new negative: 20-24 2019 33,610
PMTCT_STAT By Number of new negative: 50+ 2019 97
PMTCT_STAT By Number of new positives: 15-19 2019 109
PMTCT_STAT By Number of new positives: 20-24 2019 400
PMTCT_STAT Number of new ANC and L&D clients 2019 142,469
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 134,611
PMTCT_STAT_den 25-29, Female 2019 37,785
PMTCT_STAT_den 30-34, Female 2019 25,538
PMTCT_STAT_den 35-39, Female 2019 16,461
PMTCT_STAT_den 40-49, Female 2019 5,161
PMTCT_STAT_den By Age (Denominator): <15-19 2019 20,983
PMTCT_STAT_den By Age (Denominator): 10-14 2019 437
PMTCT_STAT_den By Age (Denominator): 20-24 2019 35,998
PMTCT_STAT_den By Age (Denominator): 50+ 2019 106
PrEP_NEW 25-29, Female 2019 154
PrEP_NEW 25-29, Male 2019 110
PrEP_NEW 30-34, Female 2019 154
PrEP_NEW 30-34, Male 2019 110
PrEP_NEW 35-39, Female 2019 132
PrEP_NEW 35-39, Male 2019 110
PrEP_NEW 40-49, Female 2019 132
PrEP_NEW 40-49, Male 2019 110
PrEP_NEW Female 15-19 2019 242
PrEP_NEW Female 20-24 2019 198
PrEP_NEW Female 50+ 2019 242
PrEP_NEW Male 15-19 2019 176
PrEP_NEW Male 20-24 2019 154
PrEP_NEW Male 50+ 2019 176
PrEP_NEW Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2019 2,200
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 19
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 542
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 10
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 502
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 1,077
TB_PREV By Age/Sex (Numerator): <15, Female 2019 598
TB_PREV By Age/Sex (Numerator): <15, Male 2019 511
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 6,813
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 8,403
TB_PREV IPT, Life-long ART, New, Positive 2019 16,326
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 16,326
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 50,351
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 1,846
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 1,574
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 21,012
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 25,915
TB_PREV_den IPT, Life-long ART, New, Positive 2019 50,351
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 86
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 1,408
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 86
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 2,051
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 3,631
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 3,903
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 86
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 1,427
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 83
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 2,307
TX_CURR 25-29, Female, Positive 2019 5,078
TX_CURR 25-29, Male, Positive 2019 3,631
TX_CURR 30-34, Female, Positive 2019 5,078
TX_CURR 30-34, Male, Positive 2019 3,631
TX_CURR 35-39, Female, Positive 2019 4,359
TX_CURR 35-39, Male, Positive 2019 3,631
TX_CURR 40-49, Female, Positive 2019 4,359
TX_CURR 40-49, Male, Positive 2019 3,631
TX_CURR Age/Sex: <1 2019 419
TX_CURR Age/Sex: <1-9 2019 3,137
TX_CURR Age/Sex: 10-14 Female 2019 847
TX_CURR Age/Sex: 10-14 Male 2019 633
TX_CURR Age/Sex: 15-19 Female 2019 7,794
TX_CURR Age/Sex: 15-19 Male 2019 5,809
TX_CURR Age/Sex: 20-24 Female 2019 6,530
TX_CURR Age/Sex: 20-24 Male 2019 5,081
TX_CURR Age/Sex: 50+ Female 2019 7,985
TX_CURR Age/Sex: 50+ Male 2019 6,001
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 77,634
TX_CURR Sum of age/sex disaggregates 2019 13,603
TX_NEW 25-29, Female, Positive 2019 215
TX_NEW 25-29, Male, Positive 2019 1,167
TX_NEW 30-34, Female, Positive 2019 215
TX_NEW 30-34, Male, Positive 2019 1,167
TX_NEW 35-39, Female, Positive 2019 215
TX_NEW 35-39, Male, Positive 2019 1,105
TX_NEW 40-49, Female, Positive 2019 215
TX_NEW 40-49, Male, Positive 2019 940
TX_NEW Breastfeeding status 2019 294
TX_NEW By Age/Sex: <1 2019 245
TX_NEW By Age/Sex: 1-9 2019 1,357
TX_NEW By Age/Sex: 10-14 Female 2019 341
TX_NEW By Age/Sex: 10-14 Male 2019 201
TX_NEW By Age/Sex: 15-19 Female 2019 3,720
TX_NEW By Age/Sex: 15-19 Male 2019 3,454
TX_NEW By Age/Sex: 20-24 Female 2019 3,172
TX_NEW By Age/Sex: 20-24 Male 2019 2,983
TX_NEW By Age/Sex: 50+ Female 2019 2,015
TX_NEW By Age/Sex: 50+ Male 2019 1,498
TX_NEW FSW 2019 221
TX_NEW MSM 2019 169
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 24,226
TX_NEW People in prisons and other enclosed settings 2019 6
TX_NEW Pregnancy status 2019 3,306
TX_NEW Sum of Age/Sex disaggregates 2019 17,384
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 73,321
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 2,101
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 2,183
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 51,344
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 17,693
TX_PVLS_den Denominator: Indication: Routine 2019 73,321
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 622
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 524
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 14,577
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 4,795
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 20,518
TX_RET Numerator by Status: Breastfeeding 2019 1,246
TX_RET Numerator by Status: Pregnant 2019 379
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 21,623
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 639
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 563
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 15,239
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 5,182
TX_RET_den Denominator by Status: Breastfeeding 2019 1,442
TX_RET_den Denominator by Status: Pregnant 2019 392
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 80,078
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 3,303
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 2,867
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2019 32,701
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2019 41,207
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 10
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2019 53
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 122
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 185
TX_TB_den Life-long ART, Already, TB Screen - Negative, Positive 2019 75,464
TX_TB_den Life-long ART, Already, TB Screen - Positive, Positive 2019 132
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 4,458
TX_TB_den Life-long ART, New, TB Screen - Positive, Positive 2019 178
Cross Cutting Budget Categories and Known Amounts Total: $91,748
Gender: Gender Based Violence (GBV) $59,123
Post GBV Care
Implementation
Collection and Use of Gender-related Strategic Information
GBV Prevention
Implementation
Capacity building
Water $32,625